Skip to content

CELGENE

Absorbed by Bristol-Myers Squibb Belgium on 30-09-2022 KBO/BCE: BE 0882.012.387 subsidiary of

Parent

United States

Acquisitions and mergers

1 transaction
BE 0403.075.184merger by absorption · Gazette deed of 28-10-2022 (4 deeds) · according to the KBO register since 30-09-2022

Connections & network

3 last directors
Depth

The network starts from the directors of CELGENE. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.